Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis

被引:35
作者
Lailulo, Yishak [1 ]
Kitenge, Marcel [1 ,2 ]
Jaffer, Shahista [1 ]
Aluko, Omololu [1 ]
Nyasulu, Peter Suwirakwenda [1 ,3 ]
机构
[1] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa
[2] Med Sans Frontieres MSF, Eshowe, Kwazulu Natal, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa
关键词
HIV; ART; Immunological failure; Virological failure; Clinical failure; Poor outcome; VIROLOGICAL FAILURE; COST-EFFECTIVENESS; INFECTED PATIENTS; DRUG-RESISTANCE; ADHERENCE; DETERMINANTS; PREDICTORS;
D O I
10.1186/s13643-020-01524-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the increase in the number of people accessing antiretroviral therapy (ART), there is limited data regarding treatment failure and its related factors among HIV-positive individuals enrolled in HIV care in resource-poor settings. This review aimed to identify factors associated with antiretroviral treatment failure among individuals living with HIV on ART in resource-poor settings. Methods: We conducted a comprehensive search on MEDLINE (PubMed), Excerpta Medica Database (EMBASE), Cochrane Central Register of Controlled Trials (CENTRAL), World Health Organization's (WHO's) library database, and Latin American and Caribbean Health Sciences Literature (LILACS). We included observational studies (cohort, case-control, and cross-sectional studies) where adolescents and adults living with HIV were on antiretroviral treatment regardless of the ART regimen. The primary outcomes of interest were immunological, virological, and clinical failure. Some of the secondary outcomes were mm(3) opportunistic infections, WHO clinical stage, and socio-demographic factors. We screened titles, abstracts, and the full texts of relevant articles in duplicate. Disagreements were resolved by consensus. We analyzed the data by doing a meta-analysis to pool the results for each outcome of interest. Results: Antiretroviral failure was nearly 6 times higher among patients who had poor adherence to treatment as compared to patients with a good treatment adherence (OR = 5.90, 95% CI 3.50, 9.94, moderate strength of evidence). The likelihood of the treatment failure was almost 5 times higher among patients with CD4 < 200 cells/mm(3) compared to those with CD4 >= 200 CD4 cells/mm(3) (OR = 4.82, 95% CI 2.44, 9.52, low strength of evidence). This result shows that poor adherence and CD4 count below < 200 cells/mm(3) are significantly associated with treatment failure among HIV-positive patients on ART in a resource-limited setting. Conclusion: This review highlights that low CD4 counts and poor adherence to ART were associated to ART treatment failure. There is a need for healthcare workers and HIV program implementers to focus on patients who have these characteristics in order to prevent ART treatment failure. Systematic review registration: The systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO), registration number: 2019 CRD42019136538.
引用
收藏
页数:17
相关论文
共 54 条
[11]   Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana [J].
Bisson, Gregory P. ;
Rowh, Adam ;
Weinstein, Rachel ;
Gaolathe, Tendani ;
Frank, Ian ;
Gross, Robert .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (01) :107-110
[12]   Current and future management of treatment failure in low- and middle-income countries [J].
Boyd, Mark A. .
CURRENT OPINION IN HIV AND AIDS, 2010, 5 (01) :83-89
[13]   How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa? [J].
Braithwaite, Ronald Scott ;
Nucifora, Kimberly A. ;
Toohey, Christopher ;
Kessler, Jason ;
Uhler, Lauren M. ;
Mentor, Sherry M. ;
Keebler, Daniel ;
Hallett, Timothy .
AIDS, 2014, 28 :S73-S83
[14]   Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015 [J].
Bulage, Lilian ;
Ssewanyana, Isaac ;
Nankabirwa, Victoria ;
Nsubuga, Fred ;
Kihembo, Christine ;
Pande, Gerald ;
Ario, Alex R. ;
Matovu, Joseph K. B. ;
Wanyenze, Rhoda K. ;
Kiyaga, Charles .
BMC INFECTIOUS DISEASES, 2017, 17
[15]   Adherence to Antiretroviral Therapy Among HIV Patients in India: A Systematic Review and Meta-analysis [J].
Chakraborty, Apurba ;
Hershow, Ronald C. ;
Qato, Dima M. ;
Stayner, Leslie ;
Dworkin, Mark S. .
AIDS AND BEHAVIOR, 2020, 24 (07) :2130-2148
[16]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[17]   Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa [J].
El-Khatib, Ziad ;
Katzenstein, David ;
Marrone, Gaetano ;
Laher, Fatima ;
Mohapi, Lerato ;
Petzold, Max ;
Morris, Lynn ;
Ekstrom, Anna Mia .
PLOS ONE, 2011, 6 (03)
[18]   Predictors of Time to First Line Antiretroviral Treatment Failure among Adult Patients Living with HIV in Public Health Facilities of Arba Minch Town, Southern Ethiopia [J].
Enderis, Bilcha Oumer ;
Hebo, Sultan Hussen ;
Debir, Mesfin Kote ;
Sidamo, Negussie Boti ;
Shimber, Mulugeta Shegaze .
ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2019, 29 (02) :175-186
[19]   Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study [J].
Estill, Janne ;
Egger, Matthias ;
Johnson, Leigh F. ;
Gsponer, Thomas ;
Wandeler, Gilles ;
Davies, Mary-Ann ;
Boulle, Andrew ;
Wood, Robin ;
Garone, Daniela ;
Stringer, Jeffrey S. A. ;
Hallett, Timothy B. ;
Keiser, Olivia .
PLOS ONE, 2013, 8 (02)
[20]   Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/μL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa [J].
Fatti, Geoffrey ;
Grimwood, Ashraf ;
Nachega, Jean B. ;
Nelson, Jenna A. ;
LaSorda, Kelsea ;
van Zyl, Gert ;
Grobbelaar, Nelis ;
Ayles, Helen ;
Hayes, Richard ;
Beyers, Nulda ;
Fidler, Sarah ;
Bock, Peter .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) :395-403